JSNM2024/JSNMT2024

Presentation information

Print

[JSNM]Oral

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » 一般演題

Oral 20:Pharmaceutical Synthesis・Quality Control 2

Thu. Nov 7, 2024 3:20 PM - 4:00 PM Room 7 (3F 304, Conference Center, PACIFICO Yokohama)

座長：古本 祥三（東北大学 先端量子ビーム科学研究センター）、淵上 剛志（金沢大学 医薬保健研究域）

[1-MO20-2] Process validation of [211At]PSMA-5 solution for investigator-initiated clinical trial

Sadahiro Naka1,2、Yoshifumi Shirakami3、Kazuhiro Ooe3、Kenta Kurimoto1,2、Toshihiro Sakai1、Yukiyoshi Kon3、Xiaojie Yin4、Hiromitsu Haba4、Atsushi Toyoshima3、Tadashi Watabe1,3、Noriyuki Tomiyama1,3 (1.Department of Radiology, Osaka University Graduate School of Medicine, Osaka, Japan、2.Department of Pharmacy, Osaka University Hospital, Osaka, Japan、3.Institute for Radiation Sciences, Osaka University, Osaka, Japan、4.Nishina Center for Accelerator-Based Science, RIKEN, Wako, Saitama)

Abstract password authentication.

The password is listed on page 9 of the Program Book.

Password